Process Engineering STREAM

  1. Small-Scale Oligonucleotide Synthesizer That Supports Scale Up 2/16/2023

    Learn about a small oligonucleotide synthesizer with big impact that features a user-friendly interface, compact footprint, and more. This small scale system is user friendly and supports scale up.

  2. Navigating The Workflow From Process Development To GMP Manufacturing For Making Clonal iPSC-Derived Master Cell Banks 3/7/2022

    In this video, we present data for optimizing choices of which combinations of GMP-compatible matrix, dissociation reagents, and media can best be employed for single cell cloning of iPSCs in process development.

  3. Accelerating Novel Cell Therapies To Market 3/20/2024

    Learn about two matrices that, when combined, provide an optimal solution for the process development and manufacturing of novel induced pluripotent stem cell therapies.

  4. Enhanced API Solubility And Stable, High Drug Loads 4/12/2017

    Poor solubility of APIs is a critical challenge in drug development. One formulation technique to address this challenge is hot melt extrusion.

  5. CDMO Hunger Games And The State Of Biotech With Siren Biotechnology's Nicole Paulk, Ph.D. 9/9/2025

    Biotech leader Nicole Paulk, Ph.D., joins “Better Biopharma” to discuss Siren Biotechnology’s switch from plasmids to producer cell lines, CGT funding challenges, and the competition that determined which CDMO won Siren’s business.

  6. Developing Antibodies To Block Neuroinflammation With MindImmune's Stevin Zorn, Ph.D. 10/20/2025

    In this episode of "Better Biopharma," host Tyler Menichiello is joined by MindImmune's president and CEO, Stevin Zorn, Ph.D. They discuss the development of the company's lead candidate, MITI-101, a monoclonal antibody designed to prevent peripheral immune cells from entering the brain and driving neuroinflammation linked to Alzheimer's disease.

  7. Parteck® SRP 80 - Reliable Sustained Drug Delivery 8/9/2017

    Parteck® SRP 80, a functional excipient based on polyvinyl alcohol (PVA), provides reliable sustained drug delivery over long release periods.